Concourse Financial Group Securities, Inc. Aziyo Biologics, Inc. Call Options Transaction History

Concourse Financial Group Securities, Inc.

$1.56 Billion
Q2 2024

Call Options

0 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form

No transaction found.

Others Institutions Holding AZYO

# of Institutions

Shares Held

8.98M

Call Options Held

893K

Put Options Held

Nantahala Capital Management, LLC New Canaan, CT

1.8M
Shares

$2.6 Million
0.17% of portfolio
Aigh Capital Management LLC Baltimore, MD

1.7M
Shares

$2.46 Million
0.89% of portfolio
Silverarc Capital Management, LLC

1.6M
Shares

$2.33 Million
0.66% of portfolio
Birchview Capital, LP Burlington, VT

1.55M
Shares

$2.25 Million
2.25% of portfolio
Perkins Capital Management Inc

780K
Shares

$1.13 Million
1.11% of portfolio

View Full List

About AZIYO BIOLOGICS, INC.

Ticker AZYO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 9,308,720
Market Cap $13.5M
Description
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...

More about AZYO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account